Mira Pharmaceuticals
BiotechnologyView the employees at
Mira Pharmaceuticals-
Michelle Yanez, MBA Chief Financial Officer/Board Member/Audit Committee Chairman/Compensation Committee/N&G Committee
-
Durham, North Carolina, United States
-
Top 5%
Rebeca Dabbah Scientific Communications Specialist-
Baltimore, Maryland, United States
-
Rising Star
-
Overview
MIRA1a is being developed to treat anxiety and cognitive decline in the elderly and neuropathic pain without impurities or the adverse side effects of cannabis plant extracts.